NO910933L - Nytt pentapeptid og fremgangsmaate for fremstilling derav. - Google Patents

Nytt pentapeptid og fremgangsmaate for fremstilling derav.

Info

Publication number
NO910933L
NO910933L NO91910933A NO910933A NO910933L NO 910933 L NO910933 L NO 910933L NO 91910933 A NO91910933 A NO 91910933A NO 910933 A NO910933 A NO 910933A NO 910933 L NO910933 L NO 910933L
Authority
NO
Norway
Prior art keywords
new
pentapeptime
preparing
procedure
pentapeptide
Prior art date
Application number
NO91910933A
Other languages
English (en)
Other versions
NO910933D0 (no
Inventor
Jan Erik Paulsen
Karl-Ludvig Reichelt
Original Assignee
Hafslund Nycomed Bioreg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hafslund Nycomed Bioreg filed Critical Hafslund Nycomed Bioreg
Priority to NO91910933A priority Critical patent/NO910933L/no
Publication of NO910933D0 publication Critical patent/NO910933D0/no
Publication of NO910933L publication Critical patent/NO910933L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C07K7/067—Hemoregulatory peptides based on sequence Glp-Glu-Asp-Cys-Lys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Nytt pentapeptid med formelen COX1 CH-, Y COX2 l II NH CH2 CH-, CH2 l ' l IT -l--CO-NH-CH-CO-NH-CH2-CO-NH-CH-CO-NH-CH-COX3 hvor Z er CH2 eller CO, Y er H eller OH, og X1, X2 og X3 er hver uavhengig av hverandre OH eller NH2 idet X2 og X3 ikke samtidig er NH2. Pentapeptidet kan benyttes som aktiv bestanddel i preparater. Fremstilling av pentapeptidet er beskrevet.
NO91910933A 1988-09-13 1991-03-08 Nytt pentapeptid og fremgangsmaate for fremstilling derav. NO910933L (no)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO91910933A NO910933L (no) 1988-09-13 1991-03-08 Nytt pentapeptid og fremgangsmaate for fremstilling derav.

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NO884054A NO884054D0 (no) 1988-09-13 1988-09-13 Nytt pentapeptid og fremgangsmaate for fremstilling derav.
PCT/NO1989/000093 WO1990002754A1 (en) 1988-09-13 1989-09-12 New pentapeptide and a process for the preparation thereof
NO91910933A NO910933L (no) 1988-09-13 1991-03-08 Nytt pentapeptid og fremgangsmaate for fremstilling derav.

Publications (2)

Publication Number Publication Date
NO910933D0 NO910933D0 (no) 1991-03-08
NO910933L true NO910933L (no) 1991-03-08

Family

ID=19891239

Family Applications (2)

Application Number Title Priority Date Filing Date
NO884054A NO884054D0 (no) 1988-09-13 1988-09-13 Nytt pentapeptid og fremgangsmaate for fremstilling derav.
NO91910933A NO910933L (no) 1988-09-13 1991-03-08 Nytt pentapeptid og fremgangsmaate for fremstilling derav.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO884054A NO884054D0 (no) 1988-09-13 1988-09-13 Nytt pentapeptid og fremgangsmaate for fremstilling derav.

Country Status (19)

Country Link
EP (2) EP0360481B1 (no)
JP (1) JPH04501710A (no)
KR (1) KR900701830A (no)
CN (1) CN1041158A (no)
AT (1) ATE102215T1 (no)
AU (1) AU623687B2 (no)
DE (1) DE68913411T2 (no)
DK (1) DK43891A (no)
ES (1) ES2062024T3 (no)
FI (1) FI911219A0 (no)
HU (2) HU206373B (no)
LV (1) LV10289B (no)
MD (1) MD503C2 (no)
MY (1) MY104912A (no)
NO (2) NO884054D0 (no)
NZ (1) NZ230625A (no)
RU (1) RU2010799C1 (no)
WO (1) WO1990002754A1 (no)
ZA (1) ZA896944B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5620957A (en) * 1989-07-14 1997-04-15 Smithkline Beecham Corporation Hemoregulatory peptides
TW222280B (no) * 1991-11-26 1994-04-11 Smithkline Beecham Corp
IL104323A0 (en) * 1992-01-10 1993-05-13 Smithkline Beecham Corp Hemoregulatory peptides
EP1739091A1 (en) * 1994-08-26 2007-01-03 Novo Nordisk A/S Trefoil peptide dimer
RU2297239C1 (ru) * 2006-05-30 2007-04-20 Общество С Ограниченной Ответственностью "Сиа Пептайдс" Пептид, стимулирующий регенерацию ткани печени, фармацевтическая композиция на его основе и способ ее применения

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2591748A (en) 1949-12-23 1952-04-08 Hercules Powder Co Ltd Amphoteric cellulose derivatives
FR2110268B1 (no) 1970-10-07 1976-06-04 Minnesota Mining & Mfg
US4237253A (en) 1977-04-21 1980-12-02 L'oreal Copolymers, their process of preparation, and cosmetic compounds containing them
NO860752L (no) * 1985-06-26 1986-12-29 Bio Tech As Pentapeptider med cellevekstregulerende virkning og fremgangsmaate for fremstilling derav.
GB8626539D0 (en) * 1986-11-06 1986-12-10 Nycomed As Peptide compounds

Also Published As

Publication number Publication date
HU895790D0 (en) 1991-11-28
WO1990002754A1 (en) 1990-03-22
EP0360481B1 (en) 1994-03-02
NO910933D0 (no) 1991-03-08
AU4224089A (en) 1990-04-02
NZ230625A (en) 1991-06-25
AU623687B2 (en) 1992-05-21
MD503B1 (en) 1996-03-29
DE68913411T2 (de) 1994-06-23
HU206373B (en) 1992-10-28
ES2062024T3 (es) 1994-12-16
LV10289A (lv) 1994-10-20
CN1041158A (zh) 1990-04-11
DK43891D0 (da) 1991-03-12
EP0434722A1 (en) 1991-07-03
LV10289B (en) 1995-04-20
DE68913411D1 (de) 1994-04-07
ATE102215T1 (de) 1994-03-15
HUT58766A (en) 1992-03-30
EP0360481A1 (en) 1990-03-28
ZA896944B (en) 1990-06-27
FI911219A7 (fi) 1991-03-12
NO884054D0 (no) 1988-09-13
JPH04501710A (ja) 1992-03-26
MY104912A (en) 1994-06-30
KR900701830A (ko) 1990-12-04
FI911219A0 (fi) 1991-03-12
RU2010799C1 (ru) 1994-04-15
DK43891A (da) 1991-03-12
MD503C2 (ro) 1996-07-31

Similar Documents

Publication Publication Date Title
ES2139574T3 (es) Nuevos gases propulsores y su uso en preparaciones medicas.
NO920051D0 (no) Farmasoeytisk sammensetning for slanking
DK0469013T3 (da) Hidtil ukendte arylpyridaziner, fremstilling deraf, anvendelse deraf og lægemidler indeholdende disse
BG45383A3 (bg) Метод за получаване на нафталинови производни
MY105314A (en) Topical composition
FI98510B (fi) Vateriitti ja menetelmä sen valmistamiseksi
ES2131528T3 (es) Nuevos polipeptidos y su uso.
SE9402880D0 (sv) New peptide derivatives
TR199900661T2 (xx) Cilt enfeksiyonlar�n�n tedavisi amac�yla 1-hidroksi-2-piridonlar�n kullan�m�
HUP9900506A2 (hu) Protrombinszármazékok
BG50159A3 (bg) Метод за получаване на производни на пиранобензоксадиазол
DK0437225T3 (da) Topiske præparater
ES2012020B3 (es) Poliisoprenos con alta proporcion de unidades estructurales 1,2 y 3,4, procedimiento para su preparacion y su empleo.
DK610287A (da) Peptider, deres fremstilling og anvendelse
FI893598A7 (fi) Sekundaarisia polyeetteriamiineja, niiden valmistus ja käyttö polyureajohdannaisten valmistukseen
BG90414A (bg) 2-азабицикло (2,2,1)-хепт-5- ен-2-оцетна киселина и нейни производни, метод за получаване и приложението им
IT8322486A0 (it) N-acetilcisteina ederivati 2',4's-carbossimetilcisteina ad-difluoro-4-idrossi-(1,1'-bifenil)attivita' antinfiammatoria, 3-carbossilici della mucolitica, procedimento per laloro preparazione e relative composizioni farmaceutiche.
NO964688L (no) Ny peptid-aktivsubstans og fremstilling av denne
ES2071343T3 (es) Nuevos peptidos con actividad anticoagulatoria.
SE9604752D0 (sv) Formulation and use
ES2013025A6 (es) Un metodo para preparar 24r-escimnol.
IT1217314B (it) Nonapeptide sintetico ad attivita'adiuvante capace di potenziare in vivo la risposta anticorporale
ATE153672T1 (de) Inhibitor gegen kollagenaseaktivität und ihn enthaltende kosmetische zubereitung
PT98764A (pt) Processo para a preparacao de composicoes contendo factor de desenvolvimento de insulina 1 completo para o tratamento terapeutico ou profilactico de estado catabolicos
MY114218A (en) The use of bambuterol or a pharmaceutically acceptable salt thereof, to make lipid lowering pharmaceutical preparations.